Enovis Total Long-Term Assets 2010-2024 | ENOV
Enovis total long-term assets from 2010 to 2024. Total long-term assets can be defined as the sum of all assets classified as non-current
| Enovis Annual Total Long-Term Assets (Millions of US $) |
|
|---|---|
| 2024 | $3,572 |
| 2023 | $3,613 |
| 2022 | $3,478 |
| 2021 | $6,213 |
| 2020 | $5,990 |
| 2019 | $5,983 |
| 2018 | $4,658 |
| 2017 | $4,640 |
| 2016 | $4,600 |
| 2015 | $5,002 |
| 2014 | $5,137 |
| 2013 | $4,469 |
| 2012 | $4,017 |
| 2011 | $737 |
| 2010 | $701 |
| 2009 | $709 |
| Enovis Quarterly Total Long-Term Assets (Millions of US $) |
|
|---|---|
| 2024-12-31 | $3,572 |
| 2024-09-30 | $4,347 |
| 2024-06-30 | $4,269 |
| 2024-03-31 | $4,328 |
| 2023-12-31 | $3,613 |
| 2023-09-30 | $3,547 |
| 2023-06-30 | $3,556 |
| 2023-03-31 | $3,466 |
| 2022-12-31 | $3,478 |
| 2022-09-30 | $3,437 |
| 2022-06-30 | $3,426 |
| 2022-03-31 | $6,136 |
| 2021-12-31 | $6,213 |
| 2021-09-30 | $6,247 |
| 2021-06-30 | $6,081 |
| 2021-03-31 | $5,989 |
| 2020-12-31 | $5,990 |
| 2020-09-30 | $5,867 |
| 2020-06-30 | $5,894 |
| 2020-03-31 | $5,874 |
| 2019-12-31 | $5,983 |
| 2019-09-30 | $6,092 |
| 2019-06-30 | $6,263 |
| 2019-03-31 | $8,094 |
| 2018-12-31 | $4,658 |
| 2018-09-30 | $4,495 |
| 2018-06-30 | $4,515 |
| 2018-03-31 | $4,716 |
| 2017-12-31 | $4,640 |
| 2017-09-30 | $4,523 |
| 2017-06-30 | $4,772 |
| 2017-03-31 | $4,649 |
| 2016-12-31 | $4,600 |
| 2016-09-30 | $4,739 |
| 2016-06-30 | $4,789 |
| 2016-03-31 | $4,939 |
| 2015-12-31 | $5,002 |
| 2015-09-30 | $5,041 |
| 2015-06-30 | $5,005 |
| 2015-03-31 | $4,923 |
| 2014-12-31 | $5,137 |
| 2014-09-30 | $5,311 |
| 2014-06-30 | $5,517 |
| 2014-03-31 | $4,429 |
| 2013-12-31 | $4,469 |
| 2013-09-30 | $3,967 |
| 2013-06-30 | $3,807 |
| 2013-03-31 | $3,860 |
| 2012-12-31 | $4,017 |
| 2012-09-30 | $3,822 |
| 2012-06-30 | $3,709 |
| 2012-03-31 | $3,792 |
| 2011-12-31 | $737 |
| 2011-09-30 | $694 |
| 2011-06-30 | $721 |
| 2011-03-31 | $728 |
| 2010-12-31 | $701 |
| 2010-09-30 | $719 |
| 2010-06-30 | $686 |
| 2010-03-31 | $705 |
| 2009-12-31 | $709 |
| 2009-09-30 | $717 |
| 2009-06-30 | $610 |
| 2009-03-31 | $606 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $2.475B | $1.707B |
| Enovis Corporation is a medical technology company. Its range of products, services and integrated technologies fuel active lifestyles in orthopedics and beyond. Enovis Corporation, formerly known as Colfax Corporation, is based in Wilmington, DE. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $36.709B | 54.09 |
| Hims & Hers Health (HIMS) | United States | $11.210B | 183.25 |
| Tempus AI (TEM) | United States | $10.954B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $5.532B | 107.78 |
| IRhythm Technologies (IRTC) | United States | $3.734B | 0.00 |
| Privia Health (PRVA) | United States | $2.941B | 245.10 |
| Clover Health Investments (CLOV) | United States | $2.095B | 0.00 |
| Azenta (AZTA) | United States | $2.083B | 96.98 |
| Omnicell (OMCL) | United States | $1.845B | 40.23 |
| Schrodinger (SDGR) | United States | $1.580B | 0.00 |
| Phreesia (PHR) | United States | $1.577B | 0.00 |
| 10x Genomics (TXG) | United States | $1.381B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.859B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.512B | 0.00 |
| Standard BioTools (LAB) | United States | $0.495B | 0.00 |
| Talkspace (TALK) | United States | $0.481B | 285.00 |
| TruBridge (TBRG) | United States | $0.423B | 123.26 |
| Nyxoah SA (NYXH) | Belgium | $0.353B | 0.00 |
| Pulmonx (LUNG) | United States | $0.352B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.305B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.257B | 0.00 |
| American Well (AMWL) | United States | $0.174B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.097B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.085B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.075B | 0.00 |
| 111 (YI) | China | $0.072B | 0.00 |
| CareCloud (CCLD) | United States | $0.054B | 0.00 |
| HeartBeam (BEAT) | United States | $0.054B | 0.00 |
| Outset Medical (OM) | United States | $0.044B | 0.00 |
| Zepp Health (ZEPP) | China | $0.042B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.038B | 0.00 |
| Zhongchao (ZCMD) | China | $0.034B | 0.00 |
| Movano (MOVE) | United States | $0.032B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.023B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.015B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.015B | 0.00 |
| Precipio (PRPO) | United States | $0.014B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.013B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| Syra Health (SYRA) | United States | $0.005B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.002B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |